SK Biopharmaceuticals Co., Ltd. (KRX: 326030)
South Korea
· Delayed Price · Currency is KRW 106,200
+3,000 (2.91%)
Feb 4, 2025, 9:00 AM KST
14.94% (1Y)
| Market Cap | 8.49T |
| Revenue (ttm) | 511.33B |
| Net Income (ttm) | 57.38B |
| Shares Out | 78.31M |
| EPS (ttm) | 732.73 |
| PE Ratio | 147.94 |
| Forward PE | 72.26 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 198,006 |
| Average Volume | 236,954 |
| Open | 104,400 |
| Previous Close | 103,200 |
| Day's Range | 103,800 - 108,000 |
| 52-Week Range | 72,600 - 130,000 |
| Beta | 0.94 |
| RSI | 49.73 |
| Earnings Date | Jan 27, 2025 |